As the industry prepares for the new age of hybrid and decentralized trials there is a heightened focus on data (quality, volume and validity), metrics and operational efficiency. These will be hot topics at the 11th annual SCOPE Summit in Orlando, and we are excited to be there as a signature sponsor, presenting and sharing our views on a number of these key industry issues.
We have seen first-hand the challenges and opportunities that have emerged from this changing clinical trial landscape through our work with global clinical trial sponsors, CROs, and others in the industry. We’ve leveraged this invaluable insight to develop Clinical One, a single, unified platform that provides universal access to information that only has to be captured once, and too common tools that can be used across all processes. During our SCOPE sessions we will discuss everything from study startup challenges, data management, to the impact that decentralized trials are having on the industry. We’ll touch on how technology plays a part in operational efficiency, which helps propel advancements in clinical research. Learn more about our sessions at SCOPE below and add us to your agenda!
February 19th, 12:15pm: “In Defense of Disruption: Overhaul Your Data Management/Analytics in Order to Leverage the Multi Data Source World”
Greg Jones, Enterprise Strategy Architect, Product Strategy, will discuss how implementing a unified platform is critical to successfully managing clinical trial data, and to realizing the full value of the data being collected today. He’ll talk about how the effect of the proliferation of new data sources can create redundancy, integrity, and analysis issues when the data is collected in silos. Building a study where data is entered just once and is then available throughout the entire process will streamline analysis, provide better insights, and make trials more cost-effective.
February 19th, 3:50pm: “Faster Recruitment, Lower Attrition, and Better Insight – Are you ready for Decentralized Trials?”
In this session, Kathy Vandebelt, Global Head of Clinical Innovation, will discuss some of the benefits and challenges facing sponsors and CROs as they add more digital data sources to clinical trials. She will review how technology is helping to minimize site visits and reduce participant attrition, while also providing rich new sources of data for investigators. She will also dive into how decentralized trials can incorporate real-world data – not just data that is collected at clinical sites – to produce a more comprehensive dataset that can be analyzed for greater insights into patient outcomes. Finally, Kathy will examine some of the challenges that the industry needs to overcome in making the transition to decentralized trials, and how Oracle Health Sciences is supporting sponsors and CROs in growing their ecosystems of digital data sources.
February 19th, 4:20pm, Roundtable – Table 29: “Virtual Trials: The New Ecosystem”
To close out day one, Kathy will be taking part of a roundtable that dives into the ins and outs of decentralized trials. She and her fellow panelists will talk about everything from the terminology the industry uses for decentralized trials, to how patient-facing technology can both help clinical trials, as well as pose challenges around the analysis of the data from this new breed of trial.
February 20th, 5:15pm, Session: “Avoid Rescue Studies, Reduce Costs and Timelines, and Accelerate Clinical Operations with Metrics”
In this session, Elvin Thalund, Director, Industry Strategy, will reveal how real-time metrics can significantly increase overall trial performance, while examining its value in identifying bottlenecks and optimizing operational processes. Real-time metrics also help to deliver a better allocation of resources, a reduction in operational timelines, and can help with both quality and regulatory compliance issues – all of which lead to getting a new therapy or device to market faster and ahead of the competition.
We hope to see you at one or all of these exciting sessions, as well as at our booth, number 405.
We look forward to meeting with you and discussing ways we can help your efforts to bring drugs to market faster.
Can't make it? Learn more about Clinical One
Contact us to learn more about how we have help you manage your clinical management needs.
2019 Video Recap - SCOPE Celebrating 10 Years